Personalized Treatment for Recurrent Vulvovaginal Candidiasis
Author Information
Author(s): Murina F., Graziottin A., Felice R., Radici G. L., Di Francesco S.
Primary Institution: Outpatient Department of Vulvar Disease, V. Buzzi Hospital, Milan, Italy
Hypothesis
Can a personalized regimen of fluconazole and probiotics reduce episodes of recurrent vulvovaginal candidiasis?
Conclusion
The study shows that a personalized treatment protocol can effectively reduce episodes of recurrent vulvovaginal candidiasis.
Supporting Evidence
- 51 out of 55 patients completed the therapy.
- 15.6% of patients experienced a recurrence before the end of therapy.
- 9.8% of patients relapsed during the follow-up period.
Takeaway
This study found that giving women a special medicine and probiotic can help stop them from getting yeast infections again.
Methodology
55 patients received fluconazole and probiotics, with a personalized regimen based on symptom resolution.
Limitations
The study had a small number of patients and a short follow-up period.
Participant Demographics
Average age of participants was 29, with a range from 21 to 44 years.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website